Use of antenatal corticosteroids for preterm birth in Latin America: providers knowledge, attitudes and practices

Alicia Aleman, Maria L Cafferata, Luz Gibbons, Fernando Althabe, Jose Ortiz, Xochitl Sandoval, Nicolás Padilla-Raygoza, José M Belizán, Alicia Aleman, Maria L Cafferata, Luz Gibbons, Fernando Althabe, Jose Ortiz, Xochitl Sandoval, Nicolás Padilla-Raygoza, José M Belizán

Abstract

Background: Antenatal corticosteroids administered to women at risk of preterm birth is an intervention which has been proved to reduce the risk of respiratory distress syndrome, intraventricular hemorrhage, and neonatal mortality. There is a significant gap in the literature regarding the prevalence of the use of antenatal corticosteroids in Latin American countries and the attitudes and opinions of providers regarding this practice. The aim of this study was to assess the knowledge, attitudes and practices of health care providers regarding the use of antenatal corticosteroids in women at risk of preterm birth in Latin America.

Methods: This was a multicenter, prospective, descriptive study conducted in maternity hospitals in Ecuador, El Salvador, Mexico and Uruguay. Physicians and midwives who provide prenatal care or intrapartum care for women delivering in the selected hospitals were approached using a self-administered questionnaire. Descriptive statistics was used.

Results: The percentage of use of ACT in threatened preterm labour (TPL) reported by providers varies from 70% in Mexico to 97% in Ecuador. However, 60% to 20% of the providers mentioned that they would not use this medication in women at risk and would limit its use when there was a threatened preterm labour. In only one country recommended regimens of antenatal corticosteroids are followed by around 90% of providers whereas in the other three countries recommended regimens are followed by only 21%, 61%, 69% of providers. Around 40% of providers mentioned that they would administer a new dose of corticosteroids again, regardless the patient already receiving an entire regimen. Between 11% and 35% of providers, according to the countries, mentioned that they do not have adequate information on the correct use of this medication.

Conclusions: This study shows that the use of this intervention could be improved by increasing the knowledge of Latin American providers on its indications, benefits, and regimens.

References

    1. MacDorman MF, Martin JA, Mathews MS, Hoyert DL. Explaining the 2001–02 Infant Mortality Increase: Data from the linked birth/infant data set. National Vital Statistics Reports. 53. Available at: , accessed January 12, 2006.
    1. Royal College of Obstetricians and Gynaecologists (RCOG) Antenatal corticosteroids to reduce neonatal morbidity and mortality. London (UK): Royal College of Obstetricians and Gynaecologists (RCOG); 2010.
    1. Crowley P. Prophylactic corticosteroids for preterm birth (Cochrane Review). The Cochrane Library, Issue 3. Oxford: Update Software; 2002.
    1. NIH Consensus Development Panel. Effect of corticosteroids for fetal maturation on perinatal outcomes. JAMA. 1995;273:413–418. doi: 10.1001/jama.1995.03520290065031.
    1. Forteza C, Díaz Rossello JL, Matijasevich A, Barros F. Morbidity and mortality of very low birth weight (VLBW) infants in Montevideo, : Abstracts from the XXXIX Annual Meeting of the Latin American Society for Pediatric Research. Colonia del Sacramento, Uruguay, nov. 2001. Pediatr Res. 2002;9:467.
    1. Krauss Silva L, Pinheiro T, Franklin R, Oliveira N. Assessment of quality of obstetric care and corticoid use in preterm labor. Cadernos de Salude Publica. 1999;15(4):1–23.
    1. Vallejo Valdivieso N, Chinga Sampedro J, Sánchez Macías M, Tumbaco García R. Epidemiología del parto pretérmino y su repercusión en la morbi-mortalidad neonatal registrados en el hospital Dr. Verdi Cevallos Balda / Epidemiología of the childbirth preterm and its repercussion in neonatal morbi-mortality registered in hospital Dr Verdi Cevallos. Medicina (Guayaquil) 2002;8(1):36–41.
    1. Colomar M, Belizán M, Cafferata ML, Labandera A, Tomasso G, Althabe F, Belizán JB. Prácticas en la atención materna y perinatal realizadas en los hospitales públicos de Uruguay. Ginecol Osbstet Mex. 2004;72:55–65.
    1. Riganti AA, Cafferata ML, Althabe F, Gibbons L, Segarra JO, Sandoval X, Belizán JM. Use of prenatal corticosteroids for preterm birth in three Latin American countries. Int J Gynaecol Obstet. 2010;108:52–57. doi: 10.1016/j.ijgo.2009.08.022.
    1. Vargas Origuel A, Leon Ramirez D, Zamora-Orozco J. Corticoesterides antenatales: Empleo y actitud del personal medico ginecoobstetra. Ginecol Obstet Mex. 2000;68:29195.
    1. Crowther Caroline A, McKinlay Christopher JD, Middleton P, Harding Jane E. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes. Cochrane Database of Systematic Reviews. The Cochrane Library, Issue 08, Art. No. CD003935.
    1. Pattanittum P, Ewens MR, Laopaiboon M, Lumbiganon P, McDonald SJ, Crowther CA. SEA-ORCHID Study Group. Use of antenatal corticosteroids prior to preterm birth in four.South East Asian countries within the SEA-ORCHID project. BMC Pregnancy Childbirth. 2008;8:47. doi: 10.1186/1471-2393-8-47.
    1. Tita A, Selwyn B, Waller K, Kapadia A, Dongmo S. Evidence-based reproductive health care in Cameroon: population-based study of awareness, use and barriers. Bull World Health Organ. 2005;83(12):895–903.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe